These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7100012)

  • 1. Hyperlipidemia therapy: can it prevent coronary atherosclerosis?
    Nash DT
    Postgrad Med; 1982 Aug; 72(2):207-11. PubMed ID: 7100012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
    Esselstyn CB
    Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future treatment of hyperlipidemia: the role of statins.
    Farnier M; Davignon J
    Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
    Deller M; Huth K
    Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of hyperlipidemia: whether, rather than how.
    Ahrens EH
    Ann Intern Med; 1976 Jul; 85(1):87-93. PubMed ID: 779574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidaemia management after primary coronary artery bypass surgery: a survey of patients and general practitioners.
    Goldsmith I; Lip GY; Emsden K; Nugent A; Patel RL
    J Cardiovasc Risk; 1999 Aug; 6(4):263-7. PubMed ID: 10501279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlipidemia. When does treatment make a difference?
    Wise GR; Schultz TT
    Postgrad Med; 1996 Jul; 100(1):138-49. PubMed ID: 8668612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK
    Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
    [No Abstract]   [Full Text] [Related]  

  • 12. Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
    Jones PH
    Curr Opin Lipidol; 1995 Dec; 6(6):365-8. PubMed ID: 8750249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid lowering drugs and coronary heart disease.
    Scott PJ
    Drugs; 1975; 10(3):218-25. PubMed ID: 1104340
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of lipids in primary and secondary prevention of cardiovascular diseases.
    Lavie CJ; Gau GT; Squires RW; Kottke BA
    Mayo Clin Proc; 1988 Jun; 63(6):605-21. PubMed ID: 3287024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of coronary heart disease risk management in high-risk patients.
    Leitha T; Staudenherz A; Bachmann B; Dudczak R
    Clin Cardiol; 1994 Mar; 17(3):123-30. PubMed ID: 8168280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of 4S evidence on baseline lipid levels.
    Durrington PN
    Lancet; 1995 Jul; 346(8968):181. PubMed ID: 7661979
    [No Abstract]   [Full Text] [Related]  

  • 20. Should pediatric patients with hyperlipidemia receive drug therapy?
    Bhatnagar D
    Paediatr Drugs; 2002; 4(4):223-30. PubMed ID: 11960511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.